Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis

por Waubant, Emmanuelle
Publicado 2006

Preventing Multiple Sclerosis: The Pediatric Perspective

por Hardy, Duriel, Chitnis, Tanuja, Waubant, Emmanuelle, Banwell, Brenda
Publicado 2022

Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review

por Castillo-Trivino, Tamara, Braithwaite, Dejana, Bacchetti, Peter, Waubant, Emmanuelle
Publicado 2013

Is multiple sclerosis a risk factor for infections?

por Lechner-Scott, Jeannette, Waubant, Emmanuelle, Levy, Michael, Hawkes, Chris, Giovannoni, Gavin
Publicado 2020

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course

por Nourbakhsh, Bardia, Bhargava, Pavan, Tremlett, Helen, Hart, Janace, Graves, Jennifer, Waubant, Emmanuelle
Publicado 2018

The COVID-19 pandemic and the use of MS disease-modifying therapies

por Giovannoni, Gavin, Hawkes, Chris, Lechner-Scott, Jeannette, Levy, Michael, Waubant, Emmanuelle, Gold, Julian
Publicado 2020

Using an animal model to predict the effective human dose for oral multiple sclerosis drugs

por Liu, Wei, Yu, Zhiheng, Wang, Ziyu, Waubant, Emmanuelle L., Zhai, Suodi, Benet, Leslie Z.
Publicado 2022

Clinical predictors of early second event in patients with clinically isolated syndrome

por Mowry, Ellen M., Pesic, Mila, Grimes, Barbara, Deen, Serina R., Bacchetti, Peter, Waubant, Emmanuelle
Publicado 2009

Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis

por Salama, Sara, Giovannoni, Gavin, Hawkes, Christopher H., Lechner-Scott, Jeannette, Waubant, Emmanuelle, Levy, Michael
Publicado 2020

Environmental and genetic risk factors for MS: an integrated review

por Waubant, Emmanuelle, Lucas, Robyn, Mowry, Ellen, Graves, Jennifer, Olsson, Tomas, Alfredsson, Lars, Langer‐Gould, Annette
Publicado 2019

Biosensor vital sign detects multiple sclerosis progression

por Krysko, Kristen M., Akhbardeh, Alireza, Arjona, Jennifer, Nourbakhsh, Bardia, Waubant, Emmanuelle, Antoine Gourraud, Pierre, Graves, Jennifer S.
Publicado 2020

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS

por Deiva, Kumaran, Huppke, Peter, Banwell, Brenda, Chitnis, Tanuja, Gärtner, Jutta, Krupp, Lauren, Waubant, Emmanuelle, Stites, Tracy, Pearce, Gregory Lewis, Merschhemke, Martin
Publicado 2020

Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity

por Mandel, Leslie A, O’Donnell, Ellen, Canenguez, Katia, Castro-Mendoza, Paola B, Lotze, Tim, Waubant, Emmanuelle, Weinstock-Guttmann, Bianca, Chitnis, Tanuja
Publicado 2021

The challenge of comorbidity in clinical trials for multiple sclerosis

por Marrie, Ruth Ann, Miller, Aaron, Sormani, Maria Pia, Thompson, Alan, Waubant, Emmanuelle, Trojano, Maria, O'Connor, Paul, Reingold, Stephen, Cohen, Jeffrey A.
Publicado 2016

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG

por Waubant, Emmanuelle, Banwell, Brenda, Wassmer, Evangeline, Sormani, Maria-Pia, Amato, Maria-Pia, Hintzen, Rogier, Krupp, Lauren, Rostásy, Kevin, Tenembaum, Silvia, Chitnis, Tanuja
Publicado 2019

A pilot study of oxidative pathways in MS fatigue: randomized trial of N‐acetyl cysteine

por Krysko, Kristen M., Bischof, Antje, Nourbakhsh, Bardia, Henry, Roland G., Revirajan, Nisha, Manguinao, Michael, Nguyen, Khang, Akula, Amit, Li, Yan, Waubant, Emmanuelle
Publicado 2021

High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics

por Lui, Allysa, Chong, Janet, Flanagan, Eoin, Abrams, Aaron W, Krysko, Kristen M, Arikan, Burak, Francisco, Carla, Rutatangwa, Alice, Waubant, Emmanuelle, Ziaei, Amin
Publicado 2021

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

por Tremlett, Helen, Fadrosh, Douglas W., Faruqi, Ali A., Hart, Janace, Roalstad, Shelly, Graves, Jennifer, Spencer, Collin M., Lynch, Susan V., Zamvil, Scott S., Waubant, Emmanuelle
Publicado 2016

Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial

por Bermel, Robert A., Waubant, Emmanuelle, Pardo, Gabriel, Bass, Ann, Repovic, Pavle, Newsome, Scott, Lindsey, John W., Kile, Deidre, Pradhan, Ashish, Musch, Bruno, Zabeti, Aram
Publicado 2021

Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study

por Krupp, Lauren, Banwell, Brenda, Chitnis, Tanuja, Deiva, Kumaran, Gaertner, Jutta, Ghezzi, Angelo, Huppke, Peter, Waubant, Emmanuelle, DeLasHeras, Virginia, Azmon, Amin, Karan, Rajesh
Publicado 2022